These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36968055)

  • 1. Exploiting butyrylcholinesterase inhibitors through a combined 3-D pharmacophore modeling, QSAR, molecular docking, and molecular dynamics investigation.
    Kumar S; Manoharan A; J J; Abdelgawad MA; Mahdi WA; Alshehri S; Ghoneim MM; Pappachen LK; Zachariah SM; Aneesh TP; Mathew B
    RSC Adv; 2023 Mar; 13(14):9513-9529. PubMed ID: 36968055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of coumarin derivatives targeting acetylcholinesterase for Alzheimer's disease by field-based 3D-QSAR, pharmacophore model-based virtual screening, molecular docking, MM/GBSA, ADME and MD Simulation study.
    Saha B; Das A; Jangid K; Kumar A; Kumar V; Jaitak V
    Curr Res Struct Biol; 2024; 7():100124. PubMed ID: 38292820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacophore mapping of the crucial mediators of acetylcholinesterase and butyrylcholinesterase dual inhibition in Alzheimer's disease.
    Adeowo FY; Elrashedy AA; Ejalonibu MA; Lawal IA; Lawal MM; Kumalo HM
    Mol Divers; 2022 Oct; 26(5):2761-2774. PubMed ID: 35067751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined QSAR, molecular docking and molecular dynamics study on new Acetylcholinesterase and Butyrylcholinesterase inhibitors.
    Daoud I; Melkemi N; Salah T; Ghalem S
    Comput Biol Chem; 2018 Jun; 74():304-326. PubMed ID: 29747032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors as Potential Anti-Alzheimer's Disease Agents Using Pharmacophore, 3D-QSAR, and Molecular Docking Approaches.
    Pang X; Fu H; Yang S; Wang L; Liu AL; Wu S; Du GH
    Molecules; 2017 Jul; 22(8):. PubMed ID: 28933746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Multi-layered Variable Selection Strategy for QSAR Modeling of Butyrylcholinesterase Inhibitors.
    Kumar V; De P; Ojha PK; Saha A; Roy K
    Curr Top Med Chem; 2020; 20(18):1601-1627. PubMed ID: 32543359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deciphering the Interactions of Bioactive Compounds in Selected Traditional Medicinal Plants against Alzheimer's Diseases via Pharmacophore Modeling, Auto-QSAR, and Molecular Docking Approaches.
    Ojo OA; Ojo AB; Okolie C; Nwakama MC; Iyobhebhe M; Evbuomwan IO; Nwonuma CO; Maimako RF; Adegboyega AE; Taiwo OA; Alsharif KF; Batiha GE
    Molecules; 2021 Apr; 26(7):. PubMed ID: 33915968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular docking and molecular dynamics approach to identify potential compounds in
    Tung BT; Hang TTT; Kim NB; Nhung NH; Linh VK; Thu DK
    J Complement Integr Med; 2022 Dec; 19(4):955-965. PubMed ID: 35621378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alignment-independent 3D-QSAR and molecular docking studies of tacrine-4-oxo-4H-Chromene hybrids as anti-Alzheimer's agents.
    Manouchehrizadeh E; Mostoufi A; Tahanpesar E; Fereidoonnezhad M
    Comput Biol Chem; 2019 Jun; 80():463-471. PubMed ID: 31170562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of Novel Acetylcholinesterase Inhibitors as Potential Candidates for the Treatment of Alzheimer's Disease.
    Son M; Park C; Rampogu S; Zeb A; Lee KW
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30823604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacophore-based drug design of AChE and BChE dual inhibitors as potential anti-Alzheimer's disease agents.
    Gao H; Jiang Y; Zhan J; Sun Y
    Bioorg Chem; 2021 Sep; 114():105149. PubMed ID: 34252860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virtual screening of acetylcholinesterase inhibitors through pharmacophore-based 3D-QSAR modeling, ADMET, molecular docking, and MD simulation studies.
    Kumar H; Datusalia AK; Khatik GL
    In Silico Pharmacol; 2024; 12(1):13. PubMed ID: 38370859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacophore model, docking, QSAR, and molecular dynamics simulation studies of substituted cyclic imides and herbal medicines as COX-2 inhibitors.
    Moussa N; Hassan A; Gharaghani S
    Heliyon; 2021 Apr; 7(4):e06605. PubMed ID: 33889764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antioxidant and Cholinesterase Inhibitory Activities of Ethyl Acetate Extract of
    Rajmohamed MA; Natarajan S; Palanisamy P; Abdulkader AM; Govindaraju A
    Pharmacogn Mag; 2017 Oct; 13(Suppl 3):S437-S445. PubMed ID: 29142396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of potential PKC inhibitors through pharmacophore designing, 3D-QSAR and molecular dynamics simulations targeting Alzheimer's disease.
    Iqbal S; Anantha Krishnan D; Gunasekaran K
    J Biomol Struct Dyn; 2018 Nov; 36(15):4029-4044. PubMed ID: 29182053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico modeling for dual inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) enzymes in Alzheimer's disease.
    Kumar V; Saha A; Roy K
    Comput Biol Chem; 2020 Oct; 88():107355. PubMed ID: 32801088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand-based pharmacophore modelling and virtual screening for the identification of amyloid-beta diagnostic molecules.
    Marondedze EF; Govender KK; Govender PP
    J Mol Graph Model; 2020 Dec; 101():107711. PubMed ID: 32898834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacophore-based drug design for the identification of novel butyrylcholinesterase inhibitors against Alzheimer's disease.
    Jiang Y; Gao H
    Phytomedicine; 2019 Feb; 54():278-290. PubMed ID: 30668379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacophore mapping-based virtual screening followed by molecular docking studies in search of potential acetylcholinesterase inhibitors as anti-Alzheimer's agents.
    Ambure P; Kar S; Roy K
    Biosystems; 2014 Feb; 116():10-20. PubMed ID: 24325852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel AChE and BChE inhibitors using combined virtual screening, text mining and in vitro binding assays.
    Sahin K; Zengin Kurt B; Sonmez F; Durdagi S
    J Biomol Struct Dyn; 2020 Jul; 38(11):3342-3358. PubMed ID: 31462153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.